Patient Comparison

Patient Comparison

side-by-side analysis comparison

Patient Alpha

72.0% riskHIGH

SHAP Waterfall

feature attribution breakdown
TCF7L2
↑ TCF7L2 pushed risk +0.34
+0.340
FTO
↑ FTO pushed risk +0.22
+0.220
SLC30A8
↑ SLC30A8 pushed risk +0.18
+0.180
PPARG
↓ PPARG reduced risk -0.15
-0.150
KCNJ11
↑ KCNJ11 pushed risk +0.12
+0.120
MTNR1B
↑ MTNR1B pushed risk +0.11
+0.110
CDKAL1
↑ CDKAL1 pushed risk +0.09
+0.090
IGF2BP2
↑ IGF2BP2 pushed risk +0.07
+0.070
CDKN2A/B
↑ CDKN2A/B pushed risk +0.05
+0.050
HHEX
↓ HHEX reduced risk -0.04
-0.040
Final Score
72.0%

Genes

TCF7L2FTOSLC30A8PPARGKCNJ11CDKAL1IGF2BP2CDKN2A/BHHEXMTNR1B

Patient Beta

38.0% riskMODERATE

SHAP Waterfall

feature attribution breakdown
TCF7L2
↑ TCF7L2 pushed risk +0.19
+0.187
FTO
↑ FTO pushed risk +0.12
+0.121
SLC30A8
↑ SLC30A8 pushed risk +0.10
+0.099
PPARG
↓ PPARG reduced risk -0.08
-0.083
KCNJ11
↑ KCNJ11 pushed risk +0.07
+0.066
MTNR1B
↑ MTNR1B pushed risk +0.06
+0.061
CDKAL1
↑ CDKAL1 pushed risk +0.05
+0.050
IGF2BP2
↑ IGF2BP2 pushed risk +0.04
+0.039
CDKN2A/B
↑ CDKN2A/B pushed risk +0.03
+0.028
HHEX
↓ HHEX reduced risk -0.02
-0.022
Final Score
38.0%

Genes

TCF7L2FTOPPARG